BEYOND MEDICAL TECHNOLOGIES INC. Financials Beyond Medical Technologies Inc. Canadian Securities Exchange
Equities
DOCT
CA0886412042
Water Utilities
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.035 CAD | -30.00% |
|
-30.00% | -36.36% |
| Jan. 24 | Beyond Medical Technologies Inc. Announces Chief Financial Officer Changes | CI |
| Jan. 24 | Beyond Medical Technologies Inc. Appoints Jatin Bakshi as Corporate Secretary | CI |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 44.87 | 21.33 | 3.665 | 5.452 | 2.69 | 0.0644 |
| Enterprise Value (EV) 1 | 40.29 | 15.15 | 0.6488 | 4.993 | 1.344 | -0.4724 |
| P/E ratio | -2.29 x | -6.46 x | -0.68 x | -0.71 x | -0.88 x | -0.05 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | 26,128,627 x | 2,850,890 x | - |
| EV / Revenue | - | - | - | 23,927,921 x | 1,424,518 x | - |
| EV / EBITDA | -20.5 x | -5.46 x | -0.2 x | -2.55 x | -0.68 x | 0.61 x |
| EV / FCF | -32.3 x | -7.91 x | -0.26 x | -3.08 x | -2.04 x | 19.9 x |
| FCF Yield | -3.1% | -12.6% | -380% | -32.5% | -49.1% | 5.02% |
| Price to Book | 8.07 x | 2.67 x | 1.04 x | 3.68 x | 1.75 x | 0.25 x |
| Nbr of stocks (in thousands) | 3,013 | 3,762 | 3,951 | 5,601 | 7,914 | 7,914 |
| Reference price 2 | 14.89 | 5.671 | 0.9275 | 0.9734 | 0.3399 | 0.008132 |
| Announcement Date | 4/26/18 | 4/29/19 | 4/28/20 | 4/30/21 | 5/2/22 | 5/1/23 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales | - | - | - | 0.2087 | 0.9434 | - |
| EBITDA 1 | -1.963 | -2.774 | -3.167 | -1.959 | -1.975 | -0.7732 |
| EBIT 1 | -1.966 | -2.799 | -3.216 | -2.029 | -2.077 | -0.7993 |
| Operating Margin | - | - | - | -972.42% | -220.1% | - |
| Earnings before Tax (EBT) 1 | -8.59 | -3.208 | -5.366 | -6.521 | -2.913 | -0.8351 |
| Net income 1 | -8.436 | -3.208 | -5.366 | -6.521 | -2.913 | -1.401 |
| Net margin | - | - | - | -3,125.16% | -308.74% | - |
| EPS 2 | -6.505 | -0.8778 | -1.362 | -1.374 | -0.3864 | -0.1770 |
| Free Cash Flow 1 | -1.248 | -1.914 | -2.469 | -1.622 | -0.6602 | -0.0237 |
| FCF margin | - | - | - | -777.4% | -69.98% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/26/18 | 4/29/19 | 4/28/20 | 4/30/21 | 5/2/22 | 5/1/23 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 4.58 | 6.19 | 3.02 | 0.46 | 1.35 | 0.54 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -1.25 | -1.91 | -2.47 | -1.62 | -0.66 | -0.02 |
| ROE (net income / shareholders' equity) | -316% | -46.2% | -91.3% | -260% | -193% | -92.7% |
| ROA (Net income/ Total Assets) | -41.3% | -24.5% | -32.6% | -44.6% | -68.4% | -39% |
| Assets 1 | 20.43 | 13.1 | 16.48 | 14.62 | 4.261 | 3.591 |
| Book Value Per Share 2 | 1.850 | 2.120 | 0.9000 | 0.2600 | 0.1900 | 0.0300 |
| Cash Flow per Share 2 | 1.490 | 0.8000 | 0.7000 | 0.1100 | 0.1800 | 0.0700 |
| Capex 1 | 0.04 | 1.59 | 1.18 | 0.23 | 0.07 | - |
| Capex / Sales | - | - | - | 112.2% | 7.21% | - |
| Announcement Date | 4/26/18 | 4/29/19 | 4/28/20 | 4/30/21 | 5/2/22 | 5/1/23 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -10.58% | 3.36B | |
| +12.14% | 1.73B | |
| +6.85% | 1.15B | |
| +0.86% | 942M | |
| -9.60% | 599M | |
| -8.92% | 562M | |
| -14.10% | 547M | |
| +1.55% | 523M | |
| -19.81% | 523M |
- Stock Market
- Equities
- DOCKF Stock
- DOCT Stock
- Financials Beyond Medical Technologies Inc.
